The latest news on neratinib post-medical insurance price in 2024

In the field of breast cancer treatment, neratinib, as a highly efficient targeted therapy drug, has significant efficacy in patients with human epidermal growth factor receptor2 (HER2)-positive breast cancer. It can effectively block the function of HER2 and inhibit the growth and division of cancer cells, thereby helping patients prolong their survival and improve their quality of life. The price of neratinib continues to change as the drug is included in Medicare. So in 2024, what will be the specific price of neratinib after medical insurance?

Regardingthe medical insurance price of neratinib in 2024, we learned that after negotiation and evaluation by the National Medical Insurance Administration, the price of neratinib has dropped significantly. However, due to differences in pharmacy pricing and medical insurance reimbursement ratios across regions, there is no clear information on the specific costs after patient reimbursement. Generally speaking, patients can purchase neratinib at hospitals or pharmacies and get reimbursement with their medical insurance cards. For specific reimbursement ratios and reimbursement procedures, patients can consult the local medical insurance department or hospital staff for detailed information. In addition, patients should note that medical insurance reimbursement usually has certain conditions, and patients who do not meet the requirements need to bear the cost of treatment themselves. For these patients, purchasing generic drugs overseas may be a good choice. Currently in Bangladesh, the version produced by Yaopin International, with a specification of 40mg*180 tablets, is priced at more than 3,000 per box, which is much cheaper than the original drug. However, when purchasing drugs overseas, in view of the potential risks, it is important to purchase through formal channels to ensure the quality and safety of the drugs.

In addition, patients should also note that whether they choose the original drug or a generic drug, neratinib, as a prescription drug, must be used under the guidance of a doctor. Patients should fully understand the indications, dosage, possible side effects and other information of the drug before use, and strictly follow the doctor's recommendations for treatment.

In short, the entry of neratinib into medical insurance has relieved a lot of burden on patients. However, patients need to consult the local medical insurance bureau for the latest news about specific medical insurance policies.